JLM-BioCity is holding its next event on Orphan Drugs from a regulatory, business and investor’s perspective, with several pharma companies sharing their experiences.

Invited speakers are:

* Yuval Cabilly, General Partner, Israel Biotech Fund

* Techiya Toaff, Director, Regulatory Affairs, Navon Pharma Group

* Alon Bloomenfeld, CEO & co-founder, Raziel Therapeutics

* Yael Gruenbaum, Director, Medison Ventures

Come and join us to hear inspiring and exceptional anecdotes!

ttps://https://lnkd.in/dqgAyrP

To get entrance to the campus and a parking space, pl fill the form below IN HEBREW